Patent ID: 8919341

Claim:
An inhaler for administering a medicament in a form of an inhalable formulation, comprising: a housing ( 3 ) having a base ( 5 ) and a cover ( 4 ) defining an internal volume and a longitudinal axis, where the cover ( 4 ) includes an entry opening ( 9 ) and an exit opening ( 8 ) in fluid communication with the internal volume; a mouthpiece ( 2 ) coupled to the cover ( 4 ) and including a longitudinally extending channel ( 15 ) in fluid communication with each of the entry opening ( 9 ) and the exit opening ( 8 ) of the cover ( 4 ); a first carrier ( 27 ) having a plurality of unsealed cavities ( 32 ), each one of the plurality of unsealed cavities ( 32 ) containing a dose of the medicament, and being disposed within the internal volume of the housing ( 3 ) towards the base ( 5 ); and a second carrier ( 26 ) having a plurality of unsealed cavities ( 32 ), each one of the plurality of unsealed cavities ( 32 ) containing a dose of the medicament, and being disposed over the first carrier ( 27 ) within the internal volume of the housing ( 3 ) towards the cover ( 4 ) along the longitudinal axis, where the second carrier ( 26 ) includes an inlet opening ( 36 ) and an outlet opening ( 35 ), each extending through the second carrier ( 26 ), wherein: the inlet opening ( 36 ) and the outlet opening ( 35 ) are movable with respect to respective ones of the plurality of unsealed cavities ( 32 ) of the first carrier ( 27 ), such that the inlet opening ( 36 ) and the outlet opening ( 35 ) operate to provide a fluidic path through the inlet opening ( 26 ) of the second carrier ( 26 ) and into a respective one of the plurality of unsealed cavities ( 32 ) of the first carrier ( 27 ), and out of the respective ones of the plurality of unsealed cavities ( 32 ) of the first carrier ( 27 ) and through the outlet opening ( 37 ) of the second carrier ( 26 ), and the entry opening ( 9 ) and the exit opening ( 8 ) of the cover are in fluidic communication with the inlet opening ( 36 ) and the outlet opening ( 35 ), respectively, of the first carrier ( 27 ), such that the fluidic path carries the medicament from the respective one of the plurality of unsealed cavities ( 32 ) of the first carrier ( 27 ) into the longitudinally extending channel ( 15 ) for delivery to a user.